US SB1391 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 9 2019 - 25% progression, died in committee
Action: 2019-05-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 9 2019 - 25% progression, died in committee
Action: 2019-05-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.
Title
Fair Accountability and Innovative Research Drug Pricing Act of 2019
Sponsors
| Sen. Tammy Baldwin [D-WI] | Sen. Mike Braun [R-IN] | Sen. Lisa Murkowski [R-AK] | Sen. Tina Smith [D-MN] |
| Sen. Angus King [I-ME] | Sen. John Hoeven [R-ND] | Sen. Kevin Cramer [R-ND] | Sen. Sherrod Brown [D-OH] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-05-09 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
Subjects
Civil actions and liability
Congressional oversight
Consumer affairs
Corporate finance and management
Government information and archives
Government studies and investigations
Health
Inflation and prices
Medical research
Prescription drugs
Research and development
Congressional oversight
Consumer affairs
Corporate finance and management
Government information and archives
Government studies and investigations
Health
Inflation and prices
Medical research
Prescription drugs
Research and development
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1391/all-info |
| Text | https://www.congress.gov/116/bills/s1391/BILLS-116s1391is.pdf |
